# Analytical Validation of the abioSCOPE Device With the in Vitro Device (IVD) CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood

> **NCT05540210** · NA · COMPLETED · sponsor: **University Hospital, Limoges** · enrollment: 100 (actual)

## Conditions studied

- Pancreatic Stone Protein
- Device

## Interventions

- **DEVICE:** measurement of PSP

## Key facts

- **NCT ID:** NCT05540210
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-29
- **Primary completion:** 2022-10-11
- **Final completion:** 2022-10-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05540210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05540210, "Analytical Validation of the abioSCOPE Device With the in Vitro Device (IVD) CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05540210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*